immunotherapy

Pharma

VacV exits stealth with systemic oncolytic viral delivery tech

VacV Biotherapeutics has taken early steps toward the validation of its systemically deliverable Vaccinia virus, exiting stealth with $3 million.
Nick Paul Taylor Oct 31, 2022 9:15am

Coherus and Junshi's cancer immunotherapy has stalled at the FDA

May 3, 2022 8:02am

BMS' Opdivo snags ultrafast FDA nod in neoadjuvant NSCLC

Mar 7, 2022 4:09am

Korean biotechs snatch U.S. stem cell manufacturing facility

Feb 13, 2019 12:00pm

New drugs, big spending: Cancer DTC spend surges to $500M

Jun 4, 2018 10:24am

Stellar Biotech starts expansion of protein production plant

Mar 30, 2018 11:04am